RESEARCH COLLABORATION AND LICENSE AGREEMENT by and between amgen inc. and ENTERABIO LTD. Dated as of December 10, 2018Research Collaboration and License Agreement • April 17th, 2019 • Entera Bio Ltd. • Biological products, (no disgnostic substances) • New York
This Research Collaboration and License Agreement (“Agreement”) is entered into as of December 10, 2018 (the “Effective Date”) by and between Amgen Inc., a Delaware corporation having an address at One Amgen Center Drive, Thousand Oaks, California 91320, USA (“Amgen”) and EnteraBio Ltd., an Israeli company having an address at Minrav Building, 5th Floor, PO Box 12117, Jerusalem 91220, Israel (“EnteraBio”). Amgen and EnteraBio are each hereafter referred to individually as a “Party” and together as the “Parties”.
